Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EVL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SEPT9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NMB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101060835 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BNIP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MXRA7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SCML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SIK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C4orf47 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HLA-DRB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ST14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EML1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COLGALT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZDHHC14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on